| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $756K | -26.3% | -31.3% |
| Cost of Revenue | $816K | -26.7% | -49.6% |
| Gross Profit | -$60K | +31.4% | +88.5% |
| R&D Expense | $40K | +92.4% | -54.0% |
| SG&A Expense | $425K | -3.6% | +23.1% |
| Operating Income | -$628K | +3.7% | +42.1% |
| Interest Expense | $7K |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $268K | -55.4% | -61.8% |
| Accounts Receivable | $225K | -16.4% | -32.6% |
| Inventory | $1.6M | -1.7% | -34.0% |
| Current Assets | $2.3M | -13.8% | -37.7% |
| Total Assets | $15.8M | +14.8% | +17.4% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$4K | — | — |
| Capital Expenditures | $59K | — | — |
| Investing Cash Flow | -$131K | — | — |
| Financing Cash Flow | -$221K | — | — |
| Free Cash Flow | -$63K | — | — |
| +0.3% |
| -0.7% |
| Pre-tax Income | -$651K | -23.3% | +41.7% |
| Net Income | -$651K | -23.3% | +41.7% |
| EPS (Basic) | -$0.17 | -6.3% | -183.3% |
| EPS (Diluted) | -$0.17 | -6.3% | -183.3% |
| $6.6M |
| +26.1% |
| +39.1% |
| Total Liabilities | $7.5M | +2.5% | +8.0% |
| Stockholders' Equity | $8.3M | +28.7% | +27.4% |